Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catharina E van Ewijk

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Annals of Intensive Care|September 4, 2016
Unsuspected serotonin toxicity in the ICUCatharina E van Ewijk, Gabriel E Jacobs, Armand R J Girbes
Vaccine|October 10, 2022
COVID-19 outbreak in an elderly care home: Very low vaccine effectiveness and late impact of booster vaccination campaignCatharina E van Ewijk, Elizabeth I Hazelhorst, Susan J M Hahné, et al.
Journal of the American Medical Directors Association|October 24, 2021
Use of a Telemedicine Team to Improve Guideline-Based Antibiotic PrescribingCatharina E van Ewijk, Caroline Schneeberger, Johanna M M Jacobs, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 11, 2022
COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021Catharina E van Ewijk, Marjolein N Kooijman, Ewout Fanoy, et al.
Epidemiology and Infection|March 27, 2025
Risk factors for invasive group A streptococcal infection in children aged 6 months to 5 years: a case-control study, the Netherlands, February-May 2023Elizabeth I Hazelhorst, Catharina E van Ewijk, Cornelia C H Wielders, et al.
Vaccine: X|December 30, 2024
Innate immune response after BNT162b2 COVID-19 vaccination associates with reactogenicityCatharina E van Ewijk, Sara Suárez Hernández, Ronald H J Jacobi, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 17, 2022
Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022Fuminari Miura, Catharina E van Ewijk, Jantien A Backer, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 24, 2024
Factors potentially contributing to the decline of the mpox outbreak in the Netherlands, 2022 and 2023Manon R Haverkate, Inge Jm Willemstein, Catharina E van Ewijk, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 23, 2026
First detection and autochthonous transmission of monkeypox virus clade Ib in the Netherlands, October to November, 2025Jelte Elsinga, Celine van de Ven, Anne de Vries, et al.
Emerging Infectious Diseases|March 10, 2022
Epidemiologic and Genomic Analysis of SARS-CoV-2 Delta Variant Superspreading Event in Nightclub, the Netherlands, June 2021Jelle Koopsen, Catharina E van Ewijk, Roisin Bavalia, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Annals of Intensive Care|September 4, 2016
Unsuspected serotonin toxicity in the ICUCatharina E van Ewijk, Gabriel E Jacobs, Armand R J Girbes
Vaccine|October 10, 2022
COVID-19 outbreak in an elderly care home: Very low vaccine effectiveness and late impact of booster vaccination campaignCatharina E van Ewijk, Elizabeth I Hazelhorst, Susan J M Hahné, et al.
Journal of the American Medical Directors Association|October 24, 2021
Use of a Telemedicine Team to Improve Guideline-Based Antibiotic PrescribingCatharina E van Ewijk, Caroline Schneeberger, Johanna M M Jacobs, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 11, 2022
COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021Catharina E van Ewijk, Marjolein N Kooijman, Ewout Fanoy, et al.
Epidemiology and Infection|March 27, 2025
Risk factors for invasive group A streptococcal infection in children aged 6 months to 5 years: a case-control study, the Netherlands, February-May 2023Elizabeth I Hazelhorst, Catharina E van Ewijk, Cornelia C H Wielders, et al.
Vaccine: X|December 30, 2024
Innate immune response after BNT162b2 COVID-19 vaccination associates with reactogenicityCatharina E van Ewijk, Sara Suárez Hernández, Ronald H J Jacobi, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 17, 2022
Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022Fuminari Miura, Catharina E van Ewijk, Jantien A Backer, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 24, 2024
Factors potentially contributing to the decline of the mpox outbreak in the Netherlands, 2022 and 2023Manon R Haverkate, Inge Jm Willemstein, Catharina E van Ewijk, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 23, 2026
First detection and autochthonous transmission of monkeypox virus clade Ib in the Netherlands, October to November, 2025Jelte Elsinga, Celine van de Ven, Anne de Vries, et al.
Emerging Infectious Diseases|March 10, 2022
Epidemiologic and Genomic Analysis of SARS-CoV-2 Delta Variant Superspreading Event in Nightclub, the Netherlands, June 2021Jelle Koopsen, Catharina E van Ewijk, Roisin Bavalia, et al.
Pageof 2